This study collects blood samples as well as clinical and self-report data from stage I-III breast cancer survivors to create a biorespository for future use. The creation of this biorepository will allow for future research into links between individual, molecular, and genomic signatures and cancer outcomes.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT05786664.
Locations matching your search criteria
United States
California
Los Angeles
Los Angeles General Medical CenterStatus: Active
Contact: Bodour Salhia
Phone: 602-565-1080
USC / Norris Comprehensive Cancer CenterStatus: Active
Contact: Bodour Salhia
Phone: 323-442-3099
PRIMARY OBJECTIVE:
I. To create an annotated biorepository with prospectively collected blood samples from breast cancer survivors.
SECONDARY OBJECTIVES:
I. To collect comprehensive data on social determinants of health (e.g., race/ethnicity, acculturation, socioeconomic status, and access to care), environmental exposures (based on zip codes/geocoding), lifestyle (e.g., diet, tobacco use), clinicopathologic characteristics, treatment history, follow-up and current disease status, survivorship-related issues.
II. To establish an efficient process for researchers to utilize the biorepository for breast cancer and survivorship-related studies.
OUTLINE:
Patients complete surveys, undergo collection of blood samples, and review of medical records on study.
Trial PhaseNo phase specified
Trial TypeNot provided by clinicaltrials.gov
Lead OrganizationUSC / Norris Comprehensive Cancer Center
Principal InvestigatorBodour Salhia
